ReviewEuropean journal of neurology2025

Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists.

Thomas Berger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.